Form4insider filings, from the source

SEC Form 4 · accession 0000950130-26-000223

KESTRA MEDICAL TECHNOLOGIES, LTD. · KMTS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey Lawrence Schwartz
Director · 10% Owner
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 8:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001877184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesF2Sep 8, 2026S3,890$25.178D7,019D
Common SharesF3Sep 9, 2026A7,217—A14,236D
Common SharesF4holding———25,172,338ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses